Recent advances in mRNA-LNP therapeutics: immunological and pharmacological aspects

In the last decade, the development of messenger RNA (mRNA) therapeutics by lipid nanoparticles (LNP) leads to facilitate clinical trial recruitment, which improves the efficacy of treatment modality to a large extent. Although mRNA-LNP vaccine platforms for the COVID-19 pandemic demonstrated high e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiaie, Seyed Hossein, Majidi Zolbanin, Naime, Ahmadi, Armin, Bagherifar, Rafieh, Valizadeh, Hadi, Kashanchi, Fatah, Jafari, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194786/
https://www.ncbi.nlm.nih.gov/pubmed/35701851
http://dx.doi.org/10.1186/s12951-022-01478-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194786/
https://www.ncbi.nlm.nih.gov/pubmed/35701851
http://dx.doi.org/10.1186/s12951-022-01478-7

Ejemplares similares